Law Firm Investigates Corporate Deals for Forte Biosciences, Arcosa, and Bio Green Med Solution
Law firm Halper Sadeh LLC is investigating transactions involving Forte Biosciences, Arcosa, and Bio Green Med Solution for potential securities law violations. The inquiry covers several corporate deals.
The law firm Halper Sadeh LLC has initiated an investigation into corporate transactions involving Forte Biosciences, Inc. (NASDAQ: FBRX), Arcosa, Inc. (NYSE: ACA), and Bio Green Med Solution, Inc. (NASDAQ: BGMS). The firm is examining whether these deals comply with federal securities laws and whether company directors have fulfilled their fiduciary duties to shareholders.
Forte Biosciences is being acquired by argenx for $77.00 per share. Arcosa is being sold to CRH for $150.00 per share. Bio Green Med Solution is merging with Future NRG Sdn. Bhd. Halper Sadeh LLC is encouraging shareholders of these companies to contact them to discuss their rights and options.
The firm stated it is investigating these transactions to determine if shareholders are receiving fair value. Halper Sadeh LLC specializes in representing investors and may seek to negotiate for increased consideration, additional disclosures, or other benefits on behalf of shareholders.
According to the firm's announcement, "Insiders may stand to receive substantial financial benefits not available to ordinary shareholders." The firm also noted that "The proposed transactions may contain terms that could limit superior competing offers." Halper Sadeh LLC emphasized that shareholders contacting them would incur no out-of-pocket costs or obligations.